← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

The Pennant Group, Inc. (PNTG) 10-Year Financial Performance & Capital Metrics

PNTG •
HealthcareHealthcare FacilitiesPost-acute and senior care
AboutThe Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.Show more
  • Revenue $948M +36.3%
  • EBITDA $60M +36.6%
  • Net Income $30M +31.1%
  • EPS (Diluted) 0.84 +18.3%
  • Gross Margin -
  • EBITDA Margin 6.38% +0.2%
  • Operating Margin 5.47% -0.1%
  • Net Margin 3.12% -3.8%
  • ROE 8.62% -12.6%
  • ROIC 5.68% +2.2%
  • Debt/Equity 1.21 +38.3%
  • Interest Coverage -
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 19.4%
  • ✓Trading near 52-week high

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Shares diluted 10.4% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y19.37%
3Y26.05%
TTM36.31%

Profit (Net Income) CAGR

10Y-
5Y13.44%
3Y64.51%
TTM31.11%

EPS CAGR

10Y-
5Y10.07%
3Y56.3%
TTM18.57%

ROCE

10Y Avg9.74%
5Y Avg4.83%
3Y Avg6.75%
Latest7.42%

Peer Comparison

Post-acute and senior care
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
PNTGThe Pennant Group, Inc.1.18B33.7140.1336.31%3.12%7.9%4.11%1.21
ENSGThe Ensign Group, Inc.12.4B214.1736.6718.72%6.8%15.46%2.99%0.93
NHCNational HealthCare Corporation2.54B163.5021.3213.23%6.75%9.57%5.86%0.08
EHCEncompass Health Corporation10.79B107.8819.4410.46%9.33%16.98%0.08
SEMSelect Medical Holdings Corporation1.85B14.9712.915.12%2.8%5.47%20.65%0.51
BKDBrookdale Senior Living Inc.3.64B15.30-13.667.29%-8.21%-308.45%5.99%
SNDASonida Senior Living, Inc.681.62M35.89-66.4619.19%-12.39%-53.82%5.03

Compare PNTG vs Peers

Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.

vs ENSG

Compare head-to-head with The Ensign Group, Inc.

vs EHC

Compare head-to-head with Encompass Health Corporation

Compare Top 5

vs ENSG, EHC, BKD, NHC

Profit & Loss

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Sales/Revenue+250.99M286.06M338.53M390.95M439.69M473.24M544.89M695.24M947.71M
Revenue Growth %-13.97%18.34%15.49%12.47%7.63%15.14%27.59%36.31%
Cost of Goods Sold+218.58M243.62M293.92M336.06M391.1M414.66M477.86M601.48M0
COGS % of Revenue87.09%85.16%86.82%85.96%88.95%87.62%87.7%86.51%-
Gross Profit+32.41M42.44M44.62M54.89M48.59M58.59M67.04M93.76M0
Gross Margin %12.91%14.84%13.18%14.04%11.05%12.38%12.3%13.49%-
Gross Profit Growth %-30.95%5.13%23.03%-11.47%20.56%14.43%39.87%-100%
Operating Expenses+17.01M21.81M38.95M35.97M43.9M45.85M41.87M55.65M71.08M
OpEx % of Revenue6.78%7.62%11.5%9.2%9.98%9.69%7.68%8%7.5%
Selling, General & Admin14.46M18.84M35.13M31.3M36.26M33.98M36.67M50.21M71.08M
SG&A % of Revenue5.76%6.59%10.38%8.01%8.25%7.18%6.73%7.22%7.5%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses2.54M2.96M3.81M4.67M7.64M11.87M5.2M5.44M0
Operating Income+15.4M20.63M5.67M18.92M4.7M12.74M25.17M38.12M51.89M
Operating Margin %6.14%7.21%1.67%4.84%1.07%2.69%4.62%5.48%5.47%
Operating Income Growth %-33.95%-72.52%233.63%-75.18%171.33%97.57%51.44%36.13%
EBITDA+17.95M23.59M9.48M23.59M9.48M17.64M30.3M44.23M60.42M
EBITDA Margin %7.15%8.25%2.8%6.03%2.16%3.73%5.56%6.36%6.38%
EBITDA Growth %-31.48%-59.82%148.86%-59.82%86.08%71.77%45.99%36.6%
D&A (Non-Cash Add-back)2.54M2.96M3.81M4.67M4.78M4.9M5.13M6.12M8.54M
EBIT15.4M20.63M5.67M19.14M4.67M12.71M25.51M38.32M0
Net Interest Income+00-410K-1.24M-1.94M-3.82M-5.92M-6.96M0
Interest Income000000000
Interest Expense00410K1.24M1.94M3.82M5.92M6.96M-6.68M
Other Income/Expense00-410K-1.01M-1.97M-3.85M-5.58M-6.75M-6.26M
Pretax Income+15.4M20.63M5.26M17.9M2.73M8.89M19.58M31.37M45.63M
Pretax Margin %6.14%7.21%1.55%4.58%0.62%1.88%3.59%4.51%4.81%
Income Tax+5.38M4.35M2.08M2.35M582K1.65M5.67M7.03M11.87M
Effective Tax Rate %64.06%76.02%48.4%87.94%98.75%74.71%68.32%71.92%64.82%
Net Income+9.87M15.68M2.55M15.74M2.7M6.64M13.38M22.56M29.58M
Net Margin %3.93%5.48%0.75%4.03%0.61%1.4%2.46%3.24%3.12%
Net Income Growth %-58.95%-83.77%518.38%-82.88%146.4%101.4%68.62%31.11%
Net Income (Continuing)10.03M16.28M3.17M15.55M2.15M7.24M13.91M24.34M29.58M
Discontinued Operations000000000
Minority Interest4.92M9.43M04.59M4.04M4.64M5.18M18.68M41.65M
EPS (Diluted)+0.350.560.090.520.070.220.440.710.84
EPS Growth %-60%-84.64%504.65%-86.52%213.84%100%61.36%18.31%
EPS (Basic)0.350.560.090.560.080.230.450.720.86
Diluted Shares Outstanding28M28M29.59M30.23M30.64M30.16M30.19M32M35.32M
Basic Shares Outstanding27.83M27.83M27.84M28.03M28.41M29.06M29.86M31.19M34.56M
Dividend Payout Ratio--455.62%------

Balance Sheet

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Current Assets+26.7M29.12M38.68M59.6M75.84M73.82M80.08M122.86M167.41M
Cash & Short-Term Investments36K41K402K43K5.19M2.08M6.06M24.25M17.02M
Cash Only36K41K402K43K5.19M2.08M6.06M24.25M17.02M
Short-Term Investments000000000
Accounts Receivable22.25M24.47M32.18M47.22M53.94M53.42M61.12M81.3M123.11M
Days Sales Outstanding32.3531.2234.744.0944.7841.240.9442.6847.41
Inventory000000000
Days Inventory Outstanding---------
Other Current Assets000016.71M18.32M12.9M17.31M27.27M
Total Non-Current Assets+61.59M69.03M409.07M447.38M454.46M438.3M459.61M556.66M800.77M
Property, Plant & Equipment8.79M10.46M330.97M326.53M317.79M287.49M291.52M313.88M336.93M
Fixed Asset Turnover28.54x27.35x1.02x1.20x1.38x1.65x1.87x2.21x2.81x
Goodwill27.96M30.89M41.23M66.44M74.27M79.5M91.01M129.12M237.25M
Intangible Assets22.88M25.21M33.46M47.49M53.73M58.62M67.74M96.18M199.44M
Long-Term Investments000000000
Other Non-Current Assets1.95M2.46M3.4M4.81M4.83M10.54M9.34M17.48M26.68M
Total Assets+88.29M98.15M447.75M506.98M530.3M512.12M539.69M679.52M968.18M
Asset Turnover2.84x2.91x0.76x0.77x0.83x0.92x1.01x1.02x0.98x
Asset Growth %-11.17%356.18%13.23%4.6%-3.43%5.38%25.91%42.48%
Total Current Liabilities+26.25M29.55M51.19M89.02M71.64M70.25M71.55M101.7M147.26M
Accounts Payable3.08M4.39M8.65M9.76M10.55M13.65M10.84M18.74M25.17M
Days Payables Outstanding5.146.5810.7510.69.8512.018.2811.37-
Short-Term Debt0000000030.01M
Deferred Revenue (Current)1.31M1.54M1.94M24.04M7.67M1.59M1.66M2.28M0
Other Current Liabilities-1.31M10.83M0013.82M1.48M13.67M705K92.08M
Current Ratio1.02x0.99x0.76x0.67x1.06x1.05x1.12x1.21x1.14x
Quick Ratio1.02x0.99x0.76x0.67x1.06x1.05x1.12x1.21x1.14x
Cash Conversion Cycle---------
Total Non-Current Liabilities+2.12M3.32M325.45M316.79M344.42M316.21M322.63M265.86M446.66M
Long-Term Debt0018.53M8.28M51.37M62.89M63.91M0423.15M
Capital Lease Obligations00304.04M296.62M287.75M247.04M248.6M253.42M0
Deferred Tax Liabilities000088.21M01.85M1.86M150K
Other Non-Current Liabilities2.12M3.32M2.88M11.9M5.29M6.28M8.26M10.57M23.36M
Total Liabilities28.37M32.86M376.64M405.8M416.05M386.46M394.18M367.56M593.93M
Total Debt+00334.86M319M355.24M326.57M329.63M273.09M453.16M
Net Debt-36K-41K334.45M318.95M350.05M324.49M323.57M248.84M436.14M
Debt / Equity--4.71x3.15x3.11x2.60x2.27x0.88x1.21x
Debt / EBITDA--35.32x13.52x37.48x18.51x10.88x6.17x7.50x
Net Debt / EBITDA-0.00x-0.00x35.28x13.52x36.93x18.40x10.68x5.63x7.22x
Interest Coverage--13.83x15.27x2.42x3.34x4.25x5.48x-
Total Equity+59.92M65.29M71.11M101.17M114.24M125.66M145.51M311.96M374.25M
Equity Growth %-8.97%8.92%42.27%12.92%9.99%15.8%114.39%19.97%
Book Value per Share2.142.332.403.353.734.174.829.7510.60
Total Shareholders' Equity55M55.86M71.11M96.58M110.2M121.01M140.34M293.28M332.6M
Common Stock55M55.86M28K28K28K29K29K35K35K
Retained Earnings00-3.8M11.95M14.64M21.28M34.66M57.22M86.8M
Treasury Stock000-65K-65K-65K-65K-65K0
Accumulated OCI000000000
Minority Interest4.92M9.43M04.59M4.04M4.64M5.18M18.68M41.65M

Cash Flow

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Cash from Operations+17.25M23.27M9.55M50.2M-18.22M9.04M33.09M39.3M48.29M
Operating CF Margin %6.87%8.14%2.82%12.84%-4.14%1.91%6.07%5.65%5.1%
Operating CF Growth %-34.93%-58.95%425.48%-136.3%149.63%265.88%18.76%22.89%
Net Income10.03M16.28M3.17M15.55M2.15M7.24M13.91M24.34M29.58M
Depreciation & Amortization2.54M2.96M3.81M4.67M4.78M4.9M5.13M6.12M0
Stock-Based Compensation2.3M2.38M3.38M8.34M10.04M3.09M5.37M7.78M0
Deferred Taxes-160K-595K79K-2.2M-1.75M1.7M4M-1.19M0
Other Non-Cash Items3.53M941K1.16M890K3.94M1.62M1.24M1.32M18.72M
Working Capital Changes-993K1.3M-2.05M22.95M-37.38M-9.5M3.44M929K0
Change in Receivables-5.71M-2.57M-8.57M-15.71M-7.33M-361K-7.35M-21.09M0
Change in Inventory3.02M1.77M269K9.67M00000
Change in Payables432K1.37M4.07M993K562K2.37M-1.84M8.05M0
Cash from Investing+-16.08M-9.48M-26.46M-41.62M-20.12M-24.24M-30.22M-70.68M-227.97M
Capital Expenditures-3.13M-3.6M-6.71M-7.25M-6.3M-14.17M-8.11M-8.99M0
CapEx % of Revenue1.25%1.26%1.98%1.86%1.43%2.99%1.49%1.29%-
Acquisitions-12.06M-4.72M-18.76M-33.19M-13.55M-10.13M-21.38M-48.42M0
Investments---------
Other Investing-891K-1.15M-991K-1.17M-267K61K-741K-13.28M-227.97M
Cash from Financing+-1.16M-13.79M17.27M-8.95M43.49M12.08M1.11M49.57M172.46M
Debt Issued (Net)0020M-10.5M44M11M500K-65M0
Equity Issued (Net)000-65K01000K579K1000K0
Dividends Paid00-11.6M000000
Share Repurchases-1.16M-1.97M-2.69M-65K00000
Other Financing-1.16M-13.79M8.87M1.62M-510K033K-4.43M172.46M
Net Change in Cash6K5K361K-359K5.15M-3.11M3.98M18.19M-7.22M
Free Cash Flow+14.12M19.67M2.84M42.95M-24.53M-5.13M24.98M30.31M48.29M
FCF Margin %5.62%6.88%0.84%10.99%-5.58%-1.08%4.59%4.36%5.1%
FCF Growth %-39.35%-85.56%1412.36%-157.1%79.1%587.42%21.3%59.35%
FCF per Share0.500.700.101.42-0.80-0.170.830.951.37
FCF Conversion (FCF/Net Income)1.75x1.48x3.75x3.19x-6.76x1.36x2.47x1.74x1.63x
Interest Paid00156K1.12M1.45M3.03M5.01M6.52M0
Taxes Paid00120K7.87M2.62M99K841K7.35M0

Key Ratios

Metric201720182019202020212022202320242025
Return on Equity (ROE)16.47%25.05%3.73%18.28%2.5%5.54%9.87%9.86%8.62%
Return on Invested Capital (ROIC)19.29%24.73%1.81%3.44%0.8%2.09%4.11%5.55%5.68%
Gross Margin12.91%14.84%13.18%14.04%11.05%12.38%12.3%13.49%-
Net Margin3.93%5.48%0.75%4.03%0.61%1.4%2.46%3.24%3.12%
Debt / Equity--4.71x3.15x3.11x2.60x2.27x0.88x1.21x
Interest Coverage--13.83x15.27x2.42x3.34x4.25x5.48x-
FCF Conversion1.75x1.48x3.75x3.19x-6.76x1.36x2.47x1.74x1.63x
Revenue Growth-13.97%18.34%15.49%12.47%7.63%15.14%27.59%36.31%

Deep Dive Analysis

Explore detailed financial history, valuation models, and returns analysis

Valuation Overview

DCF models, peer multiples & analyst estimates

Total Return Calculator

Historical returns with dividends reinvested

Dividend History

Yield, growth, payout safety & DRIP calculator

Earnings History

EPS trends, net income & profitability analysis

Price History

Long-term charts & historical price data

Revenue History

Sales growth patterns & revenue breakdown

Financial Ratios

30 years of valuation, profitability & efficiency metrics

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.